Stocktoria
SS Innovations International, Inc. SSII
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-07-09
Chart by TradingView
4/9
Piotroski F — financial health
-0.09
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $42.5M | $20.6M | $5.9M | — | — |
| Gross profit | $19.5M | $8.5M | $725,528 | $489,594 | — |
| Operating income | -$8.2M | -$19.0M | -$20.3M | -$5.7M | — |
| Net income | -$12.1M | -$19.2M | -$20.9M | -$5.6M | -$1.5M |
| Operating cash flow | -$18.5M | -$9.5M | -$15.4M | -$5.6M | -$363,034 |
| Free cash flow | -$22.2M | -$10.2M | -$15.8M | -$5.8M | — |
| Total assets | $74.2M | $42.4M | $31.5M | $8.7M | $428,607 |
| Total liabilities | $36.0M | $28.9M | $11.8M | $11.1M | — |
| Shareholders' equity | $38.2M | $13.5M | $19.7M | -$2.7M | -$166,380 |
| Ratios | |||||
| Gross margin | 46.0% | 40.9% | 12.3% | — | — |
| Operating margin | -19.3% | -91.9% | -345.1% | — | — |
| Net margin | -28.5% | -92.7% | -355.4% | — | — |
| FCF margin | -52.3% | -49.2% | -269.2% | — | — |
| Return on assets | -16.3% | -45.2% | -66.2% | -64.6% | -346.3% |
| Return on equity | -31.7% | -142.3% | -105.9% | 209.1% | 892.1% |
| Current ratio | 1.86 | 1.29 | 2.53 | 0.60 | 1.42 |
| Revenue growth | 105.7% | 251.5% | — | — | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.09 (distress)
- Working capital / assets 0.304
- Retained earnings / assets -0.752
- EBIT / assets -0.11
- Equity / liabilities 1.061
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001676163 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.